{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:27:18Z","timestamp":1791973638709,"version":"4.4.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The rapid spread of the seventh cholera pandemic over Asia in the 1960s led to several large field studies that revealed that the traditional injectable cholera vaccines had poor efficacy, which led the World Health Organization (WHO) in the 1970s to stop recommending cholera vaccination. At the same time, it stimulated research that has led to the development of the effective orally administered cholera vaccines (OCVs) that today are a cornerstone in WHO\u2019s strategy for Ending Cholera\u2014A Global Roadmap to 2030. The first effective OCV, Dukoral, containing a mixture of inactivated Vibrio cholerae bacteria and cholera toxin B subunit, was licensed in 1991 and is, together with 2 similar inactivated whole-cell OCVs, Shanchol and Euvichol, currently WHO prequalified and recommended OCVs. This brief review is a personal account of the modern history of the development of these now universally recognized effective tools.<\/jats:p>","DOI":"10.1093\/infdis\/jiab423","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T14:11:26Z","timestamp":1630159886000},"page":"S742-S748","source":"Crossref","is-referenced-by-count":21,"title":["Modern History of Cholera Vaccines and the Pivotal Role of icddr,b"],"prefix":"10.1093","volume":"224","author":[{"given":"Jan","family":"Holmgren","sequence":"first","affiliation":[{"name":"University of Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,28]]},"reference":[{"key":"2021122015214943000_CIT0001","author":"World Health Organization, Global Task Force on Cholera Control.","year":"2017"},{"key":"2021122015214943000_CIT0002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/292413a0","article-title":"Actions of cholera toxin and the prevention and treatment of cholera","volume":"292","author":"Holmgren","year":"1981","journal-title":"Nature"},{"key":"2021122015214943000_CIT0003","first-page":"106","article-title":"Cholera and the immune response","volume":"33","author":"Holmgren","year":"1983","journal-title":"Prog Allergy"},{"key":"2021122015214943000_CIT0004","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera","volume":"390","author":"Clemens","year":"2017","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/tropicalmed6020064","article-title":"An update on cholera immunity and current and future cholera vaccines","volume":"6","author":"Holmgren","year":"2021","journal-title":"Trop Med Infect Dis"},{"key":"2021122015214943000_CIT0006","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1099\/00221287-76-2-417","article-title":"Subunit structure of cholera toxin","volume":"76","author":"L\u00f6nnroth","year":"1973","journal-title":"J Gen Microbiol"},{"key":"2021122015214943000_CIT0007","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.183.4125.656","article-title":"Cholera toxin: interaction of subunits with ganglioside GM1","volume":"183","author":"Heyningen van","year":"1974","journal-title":"Science"},{"key":"2021122015214943000_CIT0008","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/iai.8.2.208-214.1973","article-title":"Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids","volume":"8","author":"Holmgren","year":"1973","journal-title":"Infect Immun"},{"key":"2021122015214943000_CIT0009","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1021\/bi00742a032","article-title":"Gangliosides and membrane receptors for cholera toxin","volume":"12","author":"Cuatrecasas","year":"1973","journal-title":"Biochemistry"},{"key":"2021122015214943000_CIT0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1172\/JCI106874","article-title":"Effect of cholera enterotoxin on ion transport across isolated ileal mucosa","volume":"51","author":"Field","year":"1972","journal-title":"J Clin Invest"},{"key":"2021122015214943000_CIT0011","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/iai.13.3.735-740.1976","article-title":"Synergistic protective effect in rabbits of immunization with V. cholerae lipopolysaccharide and toxin\/toxoid","volume":"13","author":"Svennerholm","year":"1976","journal-title":"Infect Immun"},{"key":"2021122015214943000_CIT0012","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/269602a0","article-title":"Development of improved cholera vaccine based on subunit toxoid","volume":"269","author":"Holmgren","year":"1977","journal-title":"Nature"},{"key":"2021122015214943000_CIT0013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1432-1033.1981.tb05060.x","article-title":"Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside","volume":"113","author":"Tayot","year":"1981","journal-title":"Eur J Biochem"},{"key":"2021122015214943000_CIT0014","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1073\/pnas.86.2.481","article-title":"Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development","volume":"86","author":"Sanchez","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122015214943000_CIT0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","article-title":"Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine","volume":"149","author":"Svennerholm","year":"1984","journal-title":"J Infect Dis"},{"key":"2021122015214943000_CIT0016","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/iai.55.5.1116-1120.1987","article-title":"Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin","volume":"55","author":"Black","year":"1987","journal-title":"Infect Immun"},{"key":"2021122015214943000_CIT0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0019","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"2021122015214943000_CIT0020","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(88)92189-7","article-title":"Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera","volume":"1","author":"Clemens","year":"1988","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0021","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0022","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0023","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0264-410X(96)00071-0","article-title":"Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1\/O139 whole cell cholera vaccine","volume":"14","author":"Jertborn","year":"1996","journal-title":"Vaccine"},{"key":"2021122015214943000_CIT0024","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"key":"2021122015214943000_CIT0025","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","article-title":"Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam","volume":"24","author":"Thiem","year":"2006","journal-title":"Vaccine"},{"key":"2021122015214943000_CIT0026","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0027","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2018.09.026","article-title":"The Euvichol story\u2014development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","volume":"36","author":"Odevall","year":"2018","journal-title":"Vaccine"},{"key":"2021122015214943000_CIT0028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"2021122015214943000_CIT0029","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"2021122015214943000_CIT0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cit009","article-title":"Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India","volume":"56","author":"Ali","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021122015214943000_CIT0031","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2019.12.011","article-title":"Current and future cholera vaccines","volume":"38","author":"Shaikh","year":"2020","journal-title":"Vaccine"},{"key":"2021122015214943000_CIT0032","article-title":"Cholera vaccines.","volume-title":"Plotkin\u2019s vaccines","author":"Clemens","year":"2021","edition":"8th ed."},{"key":"2021122015214943000_CIT0033","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/14760584.2017.1291348","article-title":"PaxVax CVD 103-HgR single-dose live oral cholera vaccine","volume":"16","author":"Levine","year":"2017","journal-title":"Expert Rev Vaccines"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiab423\/40078939\/jiab423.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S742\/41826217\/jiab423.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_7\/S742\/41826217\/jiab423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T15:24:12Z","timestamp":1640013852000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_7\/S742\/6359024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,28]]},"references-count":33,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2021,8,28]]},"published-print":{"date-parts":[[2021,12,20]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiab423","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,15]]},"published":{"date-parts":[[2021,8,28]]}}}